2nd or 3rd TKI-stop After 2 Years Nilotinib Pre-treatment in CML-patients

Clinical trial NCT02917720 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02917720
Sponsor: European LeukemiaNet
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia

Start date: 2016-09-01
Primary completion: 2026-09-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.